What's Happening?
The Green Mountain Care Board, Vermont's independent health care regulator, has approved modest rate increases for health insurance plans sold on Vermont Health Connect, the state's Affordable Care Act marketplace, for 2027. Individuals and small businesses
purchasing these plans will see premiums rise between 1% and 6%. Specifically, BlueCross BlueShield of Vermont's individual plans are set to increase by 2.2% and small group plans by 1.2%. MVP Health Care's individual plans will increase by 3.9% and small group plans by 6.2%. These approved increases are lower than what the insurers initially requested. The board's decision noted that the increased cost and use of pharmaceutical drugs, particularly weight loss drugs, were primary drivers for the rate increases, though BlueCross BlueShield's decision to replace some brand-name drugs with less expensive alternatives helped mitigate higher increases.
Why It's Important?
This decision by the Green Mountain Care Board impacts thousands of Vermonters and small businesses relying on the state's health insurance marketplace. While the approved increases are modest compared to national trends, they add to already high premiums in Vermont, which in 2026 had some of the highest ACA marketplace premiums nationwide. The rising costs of pharmaceutical drugs, especially new weight loss medications, are identified as a significant factor, highlighting a broader challenge in healthcare affordability across the U.S. The board's efforts to balance affordability with the financial needs of insurers, including requiring them to prepare for a 2025 law aligning hospital charges with Medicare percentages, reflect ongoing attempts to control healthcare costs. The dissent from Care Board Chair Owen Foster regarding payments to out-of-state hospitals also underscores the complex financial dynamics within the healthcare system and the challenge of retaining healthcare dollars within the state.
What's Next?
Individuals and small businesses in Vermont will experience these new premium rates starting in 2027. The Green Mountain Care Board has also issued additional orders for insurers, requiring them to prepare for a 2025 law that will align hospital charges with a percentage of Medicare. Insurers are also mandated to review payments to non-Vermont hospitals to ensure alignment with the state's affordability objectives. The board's actions and the ongoing legislative efforts aim to reduce the cost of care that insurers pay out, which could influence future premium rates. The debate over payments to out-of-state hospitals, as highlighted by Chair Foster's dissent, suggests that this will remain a contentious issue, potentially leading to further regulatory scrutiny or policy adjustments to keep healthcare spending within Vermont.
Beyond the Headlines
The situation in Vermont reflects a national struggle to contain healthcare costs, particularly within the Affordable Care Act marketplace. The significant role of pharmaceutical drug costs, especially for new and expensive medications like weight loss drugs, points to a systemic issue that impacts insurance premiums across the country. The challenge of balancing insurer solvency, consumer affordability, and the rising cost of medical services, including hospital care, is a complex one. The board's attempt to regulate payments to out-of-state hospitals also touches upon the broader economic impact of healthcare spending, where dollars spent outside the state can affect local economies and healthcare infrastructure. This ongoing tension between cost control and access to care, coupled with the influence of pharmaceutical advancements, will continue to shape health insurance policies and affordability for years to come.
